Details for 2017826439
Up to date per 02.04.2026
Actions
Details for 2017826439
Granted/Registered
European Patent
09.10.2019 A
02.09.2020 B1
05.12.2016
EP
16202175
C07C 317/44 20060101AFI20200409BHEP
Owner
Lead Pharma B.V.Kloosterstraat 9 RK5349 AB OssNL
Sanofi46 Avenue de la Grand Armée75017 ParisFR
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
CALS, Joseph Maria Gerardus Barbarac/o Lead Pharma Kloosterstraat 9 5349 AB OssNL
MACHNIK, Davidc/o Sanofi Global Intellectual Property Department Patents 54 rue La Boetie 75008 ParisFR
NABUURS, Sander Bernardusc/o Lead Pharma Kloosterstraat 9 5349 AB OssNL
SABUCO, Jean-Françoisc/o Sanofi Global Intellectual Property Department Patents 54 rue La Boetie 75008 ParisFR
Information about Fees